| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $17.27M | $21.64M | $16.81M | $23.09M | $17.21M |
| R&D | $2.81M | $6.98M | $5.45M | $9.56M | $9.13M |
| SG&A | $9.28M | $9.66M | $11.36M | $13.53M | $8.08M |
| Operating Income | -$17.27M | -$21.64M | -$16.81M | -$23.09M | -$17.21M |
| Interest Expense | $100.00K | – | – | – | – |
| Tax Expense | -$1.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$17.30M | -$19.79M | -$10.01M | -$17.75M | -$17.42M |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Shares (diluted) | $67.33B | $23.89B | $9.79B | $6.24B | $4.29B |